Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7609939

Concept	2022-01-01 to 2022-03-31	2021-01-01 to 2021-03-31
Consolidated statement of income
Statement of income
Net sales	109,717,000 JPY	89,688,000 JPY
Operating expenses
Selling, general and administrative expenses	140,706,000 JPY	136,576,000 JPY
Other	64,735,000 JPY	71,001,000 JPY
Operating expenses
Cost of sales	7,001,000 JPY	3,916,000 JPY
Net sales
Gross profit (loss)	102,715,000 JPY	85,771,000 JPY
Operating profit (loss)	-37,991,000 JPY	-50,805,000 JPY
Ordinary profit (loss)	-26,107,000 JPY	-40,944,000 JPY
Operating expenses
Research and development expenses	75,971,000 JPY	65,574,000 JPY
Non-operating income
Interest income	13,000 JPY	9,000 JPY
Other	1,000,000 JPY	132,000 JPY
Non-operating income	12,794,000 JPY	11,190,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating expenses
Interest expenses	886,000 JPY	1,216,000 JPY
Other	24,000 JPY	113,000 JPY
Non-operating expenses	910,000 JPY	1,330,000 JPY
Profit (loss) before income taxes	-26,107,000 JPY	-40,944,000 JPY
Gross profit
Income taxes - current	398,000 JPY	398,000 JPY
Income taxes	398,000 JPY	398,000 JPY
Profit (loss)	-26,506,000 JPY	-41,343,000 JPY
Profit (loss) attributable to non-controlling interests	-4,644,000 JPY	JPY
Profit (loss) attributable to owners of parent	-21,861,000 JPY	-41,343,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities	-569,000 JPY	JPY
Other comprehensive income	-569,000 JPY	JPY
Profit attributable to
Comprehensive income	-27,075,000 JPY	-41,343,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent	-22,431,000 JPY	-41,343,000 JPY
Comprehensive income attributable to non-controlling interests	-4,644,000 JPY	JPY